MAIA Biotechnology Files Definitive Proxy Statement

Ticker: MAIA · Form: DEF 14A · Filed: Apr 8, 2025 · CIK: 1878313

Sentiment: neutral

Topics: proxy-statement, annual-meeting

TL;DR

MAIA Bio's proxy statement is in, shareholders vote soon on company matters.

AI Summary

MAIA Biotechnology, Inc. filed its definitive proxy statement (DEF 14A) on April 8, 2025, for its annual meeting on May 22, 2025. The filing concerns the solicitation of proxies from shareholders regarding matters to be voted on at the meeting. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the upcoming annual meeting and provides information necessary for them to cast their votes on important company matters.

Risk Assessment

Risk Level: low — This is a routine filing for a proxy statement, not indicating any immediate financial or operational risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

The purpose of this DEF 14A filing is to provide shareholders with information required for the solicitation of proxies for the annual meeting of MAIA Biotechnology, Inc.

When is the annual meeting of MAIA Biotechnology, Inc. scheduled?

The annual meeting of MAIA Biotechnology, Inc. is scheduled for May 22, 2025.

What is the filing date of this definitive proxy statement?

This definitive proxy statement was filed on April 8, 2025.

What is the company's Central Index Key (CIK)?

MAIA Biotechnology, Inc.'s Central Index Key (CIK) is 0001878313.

Where is MAIA Biotechnology, Inc. incorporated?

MAIA Biotechnology, Inc. is incorporated in Delaware (DE).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 8, 2025 regarding MAIA Biotechnology, Inc. (MAIA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing